v3.26.1
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Federal grants $ 960,999 $ 1,319,772
Operating expenses:    
Research and development 3,346,881 1,885,528
General and administrative 1,176,348 1,401,756
Total operating expenses 4,523,229 3,287,284
Loss from operations (3,562,230) (1,967,512)
Other income (expense):    
Change in fair value of liability classified warrants 9,916
Interest expense, net (3,923) (3,856)
Other income and expense, net 9,738 15,879
Total other income (expense), net 5,815 21,939
Net loss (3,556,415) (1,945,573)
Net loss attributable to common stockholders $ (3,556,415) $ (1,945,573)
Net loss per basic and diluted share:    
Net loss per share attributable to common stockholders, basic $ (0.52) $ (1.39)
Net loss per share attributable to common stockholders, diluted $ (0.52) $ (1.39)
Weighted average common shares outstanding, basic 6,839,385 1,401,144
Weighted average common shares outstanding, diluted 6,839,385 1,401,144

Source

PDF HTML
ZIP XBRL